Dr. Linsey Ittyipe, FNP-C
What this data tells you about Dr. Ittyipe
Dr. Linsey Ittyipe is a nurse practitioner - family in Bellaire, TX, with 6 years in practice. Based on federal Medicare data, Dr. Ittyipe performed 61,233 Medicare services across 1,367 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ittyipe received a total of $1,042 from 17 pharmaceutical and/or device companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ittyipe is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 29,820 | $8 | $31 |
| Denosumab injection (Prolia/Xgeva) | 11,940 | $18 | $89 |
| Iron sucrose injection (Venofer) | 4,400 | $0 | $2 |
| Injection, mepolizumab, 1 mg | 3,900 | $23 | $109 |
| Injection, tildrakizumab, 1 mg | 3,200 | $109 | $501 |
| Omalizumab injection (Xolair) for asthma/allergy | 3,195 | $30 | $135 |
| Infliximab infusion (Remicade) | 1,324 | $26 | $409 |
| Injection, benralizumab, 1 mg | 1,230 | $129 | $596 |
| Drug injection, under skin or into muscle | 370 | $10 | $50 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 345 | $49 | $300 |
| Injection, zoledronic acid, 1 mg | 305 | $6 | $252 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 277 | $43 | $250 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 190 | $14 | $125 |
| Office visit, established patient (20-29 min) | 159 | $54 | $135 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 111 | $4 | $43 |
| Administration of chemotherapy into vein, each additional hour | 110 | $19 | $125 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 102 | $20 | $250 |
| Administration of chemotherapy into vein, 1 hour or less | 95 | $89 | $500 |
| New patient office visit (30-44 min) | 81 | $69 | $245 |
| Office visit, established patient (30-39 min) | 29 | $72 | $210 |
| Injection, diphenhydramine hcl, up to 50 mg | 28 | $1 | $16 |
| New patient office visit (45-59 min) | 22 | $104 | $345 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ittyipe is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ittyipe experienced with romosozumab injection (evenity) for osteoporosis?
Does Dr. Ittyipe receive payments from pharmaceutical companies?
How do Dr. Ittyipe's costs compare to other nurse practitioner - familys in Bellaire?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology